Back to Main

Faculty Detail    
Name ROBERTA MAY
 
Campus Address SC 1034 Zip 0017
Phone  205-934-2605
E-mail  bmay@uab.edu
Other websites
     

Education
Undergraduate  University of Alabama     1966  BA 
Graduate  University of Alabama at Birmingham    1985  MA 

Certifications
CCRC  1985 


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Psychiatry   Psych - Behavioral Neurobiology Associate Professor

Biographical Sketch 
1981-1982 - Research Assistant, Department of Psychiatry, Consultation/Liaison Service, University of Alabama at Birmingham School of Medicine, UAB. 1984 1990 - Research Assistant, Psychology Service, Birmingham, Alabama, Veterans Administration Medical Center. 1982 1994 Faculty Associate/Research Associate, Department of Psychiatry and Behavioral Neurobiology, University of Alabama School of Medicine, UAB. 1994 1998 Faculty Instructor/Associate, Director for Administration for Clinical Psychopharmacology Studies, Department of Psychiatry and Behavioral Neurobiology, UAB. 1998 present Assistant Professor/Director, Office of Psychiatric Research, Department of Psychiatry and Behavioral Neurobiology, UAB.

Society Memberships
Organization Name Position Held Org Link
Association of Clinical Research Professionals  Member  http://www.acrpnet.org 



Research/Clinical Interest
Title
Mood Disorders
Description
As Director of the Office of Psychiatric Clinical Research, my current research interests include adjunctive treatment for treatment resistant depression; a comparison of lithium and Seroquel for treatment of bipolar disorder; development of a diagnostic test for depression; evaluation of ketamine, l-methyfolate, and other novel compounds as treatment for depression and/or suicidal ideation; low field magnetic stimulation for treatment resistant depression; oxidative stress mechanisms in mood disorders; and exploration of biomarkers for psychiatric disorders.

Selected Publications 
Publication PUBMEDID
Reeves H, Batra S, May RS, Zhang R, Dahl DC, Li X: “Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study,” J Clinical Psychiatry 69(8):1228-36, 2008.   18681749 
Li X, Friedman AB, Zhu W, Boswell S, May RS, Davis LL, Jope RS: “Lithium Regulates Glycogen Synthase Kinase-3 in Human Peripheral Blood Mononuclear Cells: Implication in the Treatment of Bipolar Disorder,” Biological Psychiatry, 61:216-222, 2007.   1853347 
Savage RM, Weiner HW, Nimgaonkar V, Devlin B, Calkins ME, Gur RE, O’Jile J, Bradford LD, Edwards N, Kwentus J, McEvoy JP, Nasrallah H, Santos AB, Aduroja T, Allen T, Lahti A, May RS, Montgomery-Barefield L, Go RCP: “ Heritability of Functioning in Families with Schizophrenia in Relation to Neurocognition,” Schizophrenia Research, published online ahead of print 23 May 2012.   22627125  
Fargason RE, Gamble k, Avis KT, Besing RC, Jackson C, Cates M, May R: “Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD),” Psychopharmacology Bulletin, 44(2) 2011.   
Aliyu MH, Calkins ME, Swanson CL, Lyons PD, Savage RM, May RS, Wiener H, Devlin B, Nimgaonkar VL, Ragland JD, Gur RE, Gur RC, Bradford LD, Edwards N, Kwentus J, McEvoy J, Santos AB, McLeod-Bryant S, Tennison C, Go RCP: “Project among African-Americans to explore risks for schizophrenia (PAARTNERS): Recruitment and assessment methods,” Schizophrenia Research, 87/1-3:32-44, October 2006.    
Hamilton LA, Aliyu MH, Lyons PD, May RS, Swanson CL, Savage RM, Go RCP: “African-American Community Attitudes and Perceptions toward Schizophrenia and Medical Research: An Exploratory Study, “ Journal of the National Medical Association, 98 (1), January 2006.   
Wang, X., Savage, R., Borisov, A., Rosenberg, J., Woolwine, B., Tucker, M., May, R., Feldman, J., Nemeroff, CB., and Miller, AH. Efficacy of Risperidone versus Olanzapine in Patients with Schizophrenia Previously on Chronic Conventional Antipsychotic Therapy: A Switch Study. Journal of Psychiatric Research. 40: 669-676, 2006.   
Li X, May RS, Tolbert LC, Jackson WT, Flournoy JM, Baxter LR: “Risperidone and Haloperidol Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder,” Journal of Clinical Psychiatry, 66(6), June 2005.   
Markovitz J H, Shuster J, Chitwood W, May RS, Tolbert LC: Platelet Activation in Depression and Effects of Sertraline Treatment: An Open-Label Study, American Journal of Psychiatry 157 (6):1006-1008, June, 2000.   
Li X, Jackson WT, May RS: (Abstract & Poster) “Risperidone vs. Haloperidol Augmentation in SSRI Refractory OCD- Preliminary Report,” of American College of Neuropsychopharmacology Annual Meeting Mexico, December, 1999.   
Freeman AM, Davis LL, Libb JW, Sokol RS: Psychiatric Morbidity in Three Stages of Myocardial Infarction, Coronary Bypass Surgery and Cardiac Transplantation. American Journal of Preventive Psychiatry and Neurology 2 (2) : 6-11, March 1990.   
Folks DG, Freeman AM, Sokol RS, Thurstin AH: Denial: Predictor of Outcome following Coronary Bypass Surgery. International Journal Psychiatry in Medicine 18 (1) : 57-68, 1988.   
Folks DG, Freeman AM, Sokol RS, Govier AV, Reeves JG, Baker DM: Cognitive Dysfunction After Coronary Bypass Surgery: A Case Controlled Study. Southern Medical Journal 81 (2) : 202-206, 1988.   
Folks DG, Blake DJ, Freeman AM, Sokol RS, Baker DM: Persistent Depression Coronary Bypass Patients Reporting Sexual Maladjustment. Psychosomatics 29 (4) : 387-391, 1988.